Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients-Reference-Cited by-同舟云学术

Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients

Published:2009-10-28 Issue:11 Volume:15 Page:1557-1563
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Askar Medhat,Avery Robin,Corey Rebecca,Lopez Rocio,Thomas Dawn,Pidwell Diane,Eghtesad Bijan,Miller Charles,Fung John,Zein Nizar N.

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/lt.21878/fullpdf

Reference39 articles.

1. Global epidemiology of hepatitis C virus infection;Shepard;Lancet Infect Dis,2005

2. Recurrent and acquired hepatitis C viral infection in liver transplant recipients;Wright;Gastroenterology,1992

3. Hepatitis C and liver transplantation;Berenguer;J Hepatol,2001

4. The natural history of recurrent hepatitis C and what influences this;Gane;Liver Transpl,2008

5. Long-term outcome of hepatitis C infection after liver transplantation;Gane;N Engl J Med,1996

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The outlook for precision medicine for the treatment of chronic hepatitis C infection: challenges and opportunities;Expert Review of Precision Medicine and Drug Development;2020-06-09

2. IN SILICO SCREENING AND MOLECULAR DYNAMIC SIMULATION STUDIES OF POTENTIAL SMALL MOLECULE IMMUNOMODULATORS OF THE KIR2DS2 RECEPTOR;2020-05-12

3. Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients;International Journal of Molecular Sciences;2019-01-28

4. Pharmacogenetics and the treatment of HIV-/HCV-coinfected patients;Pharmacogenomics;2018-08-01

5. Diversity of Killer Cell Immunoglobulin-Like Receptor (KIR) Genotypes and KIR2DL2/3 Variants in HCV Treatment Outcome;PLoS ONE;2014-06-13